• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Use of oral anticholinergic therapy in children under 1 years of age with high risk bladder].

作者信息

Luque Mialdea R, Martín-Crespo R, Hernández E, Sánchez O, Cañizo A, Fernández A, Aparicio C, Blanco T, Cebrían J

机构信息

Sección Urología Pediátrica, Servicio Cirugía Pediátrica, Hospital Sur de Alcorcón, Unidad de Urodinamia, Sanatorio Nuestra Señora del Rosario, Madrid.

出版信息

Cir Pediatr. 2005 Jan;18(1):3-7.

PMID:15901100
Abstract

THE AIM

To assess the effectiveness and safety of the treatment with oral anticholinergic agents (Oxybutin clorure) in patients under 1 year old, and who aree carriers of high risk bladder secondary to neurological illness as well as no neurological one.

MATERIAL AND METHODS

Since 1989, we have indicated treatment with anticholinergic agents to 16 patients: 9 patients had neurogenic bladder secondary to: myelomeningocele (n=7) and sacrocoxigeal teratoma (n=2). Others 7 patients had non neurogenic bladder secondary to: posterior urethral valvulas (n=1), valvula-like syndrome (n=4), post-surgery of neonatal giant bladder diverticulum (n=1) and Prune-Belly syndrome (n=1). The urodinamic study was performed during the first six months of life, being "high risk bladder" defined according to the parameters of compliance vesical and pressure of leak at point (PER). Five of the patients showed neonatal cronic renal failure (CRF), who were treated by cutaneus temporary derivation. All patients at treatment with anticholinergic agents at a 0.2 mg/kg/day dose was established; other early adjunctive treatment prior to the closure of the urinary derivation in children with CRF(n=5); or as a part of the conservative treatment (n=3), alone or associate to intermittent bladder catheterization (IBC) (n=8). During the treatment with anticholinergic agents, the cardiac frequency was controlled by EKG registration in 6 patients, being the rest of the children clinicaly controled (skin colour, mouth dryness, cardiac frequency and intestinal function).

RESULTS

In all the cases, the minimum duration of the treatment was one year, until the functional stabilization of the urinary tract. It is to underline the absence of secondary complications which would have caused the suspension or the reduction of the treatment at long term. Conventional studies of urologicals image and urodinamic studies, showed the stabilization of the urinary tract and also the preservation of kidney function and not only was demonstrated in those patients with oral anticholinergic agent as their unique treatment, but also in those patients who had previously been derivated. The previous vesical stabilization allowed the optimum result of subsequent corrective surgeries in five patients (ureteroneocystostomy and vesiscotomy clousure. In cases with previous derivation, the treatment with oral anticholinergic agents made easier vesicostomic clousure in the forth quarter of the first year old wih the maintenance of the vesical stability.

CONCLUSIONS

The use of oral anticholinergic agents at a dose of 0.2 mg/kg/day, has resulted to be safe as well as effective in the treatment of high risk bladder in infancy those with less than one year of life. In those patients with serious dysplasia by reflux, it contributes to the preservation of kidney function, it makes easier the early desderivation and it also stabilizes in a functional way the bladder as a previous step to subsequent reconstructive surgeries.

摘要

相似文献

1
[Use of oral anticholinergic therapy in children under 1 years of age with high risk bladder].
Cir Pediatr. 2005 Jan;18(1):3-7.
2
Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.保守治疗的脊髓脊膜膨出患儿青春期后的尿动力学及上尿路变化
J Urol. 2007 Oct;178(4 Pt 1):1479-82. doi: 10.1016/j.juro.2007.05.171. Epub 2007 Aug 16.
3
Detrusor overactivity in spina bifida: how long does it need to be treated?脊柱裂患者逼尿肌过度活动症:需要治疗多长时间?
Neurourol Urodyn. 2004;23(7):685-8. doi: 10.1002/nau.20044.
4
Does surgical release of secondary spinal cord tethering improve the prognosis of neurogenic bladder in children with myelomeningocele?继发性脊髓栓系松解术能否改善脊髓脊膜膨出患儿神经源性膀胱的预后?
J Urol. 2006 Oct;176(4 Pt 1):1601-6; discussion 1606. doi: 10.1016/j.juro.2006.06.036.
5
[The use of intravesical oxybutynin hydrochloride in patients with neurogenic bladder managed by intermittent catheterization].[盐酸奥昔布宁在间歇性导尿管理的神经源性膀胱患者中的应用]
Hinyokika Kiyo. 1995 Jul;41(7):521-4.
6
Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction.奥昔布宁治疗神经源性膀胱功能障碍继发逼尿肌反射亢进患儿的疗效与安全性。
J Urol. 2005 Jan;173(1):221-5. doi: 10.1097/01.ju.0000147813.28822.d2.
7
Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population.小儿脊髓脊膜膨出患者膀胱内注射氯化奥昔布宁治疗的并发症
J Urol. 1997 Feb;157(2):638-40.
8
Propiverine compared to oxybutynin in neurogenic detrusor overactivity--results of a randomized, double-blind, multicenter clinical study.在神经源性逼尿肌过度活动中丙哌维林与奥昔布宁的比较——一项随机、双盲、多中心临床研究的结果
Eur Urol. 2007 Jan;51(1):235-42. doi: 10.1016/j.eururo.2006.03.016. Epub 2006 May 2.
9
Total endoscopic management (TEM approach) of children with non-compliant neuropathic bladder: a preliminary report.非顺应性神经源性膀胱患儿的全内镜治疗(TEM 方法):初步报告
J Pediatr Urol. 2008 Apr;4(2):124-6. doi: 10.1016/j.jpurol.2007.10.008. Epub 2008 Jan 2.
10
Pediatric renal transplantation and the dysfunctional bladder.小儿肾移植与功能障碍性膀胱
Transpl Int. 2004 Nov;17(10):596-602. doi: 10.1007/s00147-004-0784-6. Epub 2004 Oct 29.

引用本文的文献

1
Intravesical Oxybutynin for Urgent Bladder Rescue in a Newborn with Posterior Urethral Valves.膀胱内注射奥昔布宁用于后尿道瓣膜新生儿的紧急膀胱抢救
European J Pediatr Surg Rep. 2019 Jan;7(1):e90-e92. doi: 10.1055/s-0039-3399565. Epub 2019 Nov 22.